Next Generation Sequencing (NGS) methods are rapidly providing remarkable advances in our ability to study the molecular profiles of human cancers. However, the scientific discovery offered by NGS also includes challenges concerning the interpretation of large and non-trivial experimental results. This task is potentially further complicated when a multitude of molecular profiling modalities are available, with the goal of a more integrative and comprehensive analysis of the cancer biology.
['Michael Anthony Bauer', 'Shweta S. Chavan', 'Erich Allen Peterson', 'Christoph Heuck', 'Donald Johann']
Leveraging the new with the old: providing a framework for the integration of historic microarray studies with next generation sequencing